Skip to content
healthcare.dev

rufinamide

NDC 68462-713, rufinamide, tablet, film coated, from Glenmark Pharmaceuticals Inc., USA.

Product NDC
68462-713
Status
Listed
Labeler
Glenmark Pharmaceuticals Inc., USA
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205075
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68462-713 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RUFINAMIDE200 mg/1
Package NDCNDC-11Package
68462-713-0568462071305500 TABLET, FILM COATED in 1 BOTTLE (68462-713-05)
68462-713-0868462071308120 TABLET, FILM COATED in 1 BOTTLE (68462-713-08)
68462-713-306846207133030 TABLET, FILM COATED in 1 BOTTLE (68462-713-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/da9ee326-a383-4d46-9d4e-fcc2be3d2680
  • NADAC price for package 68462071308

    GET /v1/drugs/nadac/68462071308

Use it

Look up 68462-713 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68462-713 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68462-713. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.